Pictet Asset Management Holding SA reduced its stake in Altria Group by 3.6% in the first quarter, selling 28,893 shares and retaining 769,254 shares valued at $50.8 million. Altria recently exceeded earnings and revenue estimates, reporting EPS of $1.32 and revenue of $4.76 billion, while also raising its FY 2026 EPS guidance. The company maintains an attractive dividend yield of 5.7% but analysts generally rate the stock as "Hold."

Pictet Asset Management Holding SA significantly increased its stake in Cummins Inc. during the first quarter by 11.9%, now holding 112,055 shares valued at over $60 million. Wall Street analysts maintain a "Moderate Buy" consensus rating for CMI, with an average target price of $731.86. Cummins recently exceeded earnings expectations, reporting a strong EPS of $6.15 and revenue of $8.40 billion, and also paid a quarterly dividend of $2.00 per share.

Katie Saez started her career at Truist's predecessor, SunTrust, right out of college and has steadily climbed the ranks to become Truist's Georgia regional president. She played a crucial role in the merger that formed Truist and now leads various banking sectors in Georgia, focusing on leveraging AI and technology for improved client solutions. Saez shares insights on her leadership style, morning routine, and the importance of building human relationships in the business world.

Delta Air Lines is bringing back Fresca to its onboard beverage lineup starting July 1st, a much-requested item from customers. The airline is also updating its snack offerings with Rold Gold Tiny Twists Original Pretzels and has introduced perks for T-Mobile customers and Delta SkyMiles American Express Card Members, offering complimentary premium drinks and snacks respectively. These changes reflect Delta's commitment to enhancing the customer experience based on feedback.

Hormel Foods Corporation has announced a definitive agreement to sell its Brazilian operations, branded CERATTI®, to Zanchetta Alimentos LTDA. This divestiture aligns with Hormel Foods' strategy to simplify its portfolio and focus international efforts on high-growth markets. The transaction is expected to close in the coming weeks and will have a minimal impact on Hormel Foods' adjusted fiscal 2026 financial results.

Patriot Financial Group Insurance Agency LLC recently acquired 19,564 shares of Sysco Corporation (SYY) valued at approximately $1.396 million in Q1. Other institutional investors have also adjusted their holdings in SYY, and a company director recently bought over 13,000 shares. Analyst sentiment is mixed, with some downgrades, but the consensus remains a "Moderate Buy" with a target price of $88.15, while Sysco also increased its quarterly dividend to $0.55 per share.

Patriot Financial Group Insurance Agency LLC significantly increased its stake in Take-Two Interactive Software, Inc. ($TTWO) during the first quarter, now holding 5,744 shares valued at $1.13 million. Other institutional investors also boosted their holdings, with institutions and hedge funds collectively owning 95.46% of the company's stock. Analysts maintain a "Moderate Buy" rating for TTWO, with an average target price of $292.71, while the stock traded up 3.6% at $247.15.

Janney Montgomery Scott LLC reduced its stake in Vistra Corp. by 11.3% in the first quarter, selling 22,740 shares, though other institutional investors increased their holdings. Insider activity also saw directors Scott B. Helm and John R. Sult sell a combined total of over $5 million worth of company stock. Vistra Corp. recently reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend.

Business First Bancshares, Inc. director Joseph Vernon Johnson reported receiving 998 time-based restricted stock units (RSUs) on June 25, 2026, which vest fully on June 25, 2027. He also exercised 1,016 previously granted time-based restricted stock units on June 26, 2026, converting them into common stock at $0.00 per share. Following these transactions, Johnson directly holds 184,073 shares of common stock and 998 unvested RSUs.

AstraZeneca has released new bone health data for its Strensiq successor. The article, published on June 29, 2026, highlights developments from AstraZeneca PLC, Alexion Pharmaceuticals Inc., and AM-Pharma B.V. on treatments for rare diseases, particularly focusing on bone health.